Muralidhar L. Hegde
Dr. Hegde is an Associate Professor at Houston Methodist Research Institute, an affiliate of Cornell University, in Houston, Texas, USA. He also hold adjunct Professor Appointments at Texas A & M University and INDICASAT, Panama. Recently he was awarded a distinguished Visiting Professorship in Tianjin University China under the prestigious Thousands Talents program. Dr. Hegde directs a research program focused on delineating the molecular insights in to the involvement of genome damage/repair responses in human brain pathologies and developing novel mechanism-based treatment strategies for these diseases. Dr. Hegde’s lab utilizes state-of-the art molecular biology/gene editing technologies, human induced pluripotent cell derived neuronal models, as well relevant mice models. Dr. Hegde has published more than 75 research papers in prestigious journals like Nature Communications, Cell Reports, PNAS and JBCs. Dr. Hegde’s research has been continuously funded by National Institute of Health, Muscular Dystrophy Association, ALS Association, Melo Foundation, Alzheimer’s Association etc. He was one of the youngest to be awarded a 2-million dollar NIH R01 grant award at 37 years of age, in 2015. Dr. Hegde has also been a member of NIH and DOD study sections, grant review boards for the Alzheimer’s Association, USA, and grant review boards in Netherlands, France, UK and India. He is deputy chief editor of springer journal Metabolic Brain Diseases, Associate Editor for the Journal of Alzheimer’s Disease and serves on the editorial boards of another half-a-dozen journals. He is invited to review articles routinely for more than 50 international journals.